CLEERLY™ VS. HEARTFLOW ™ VS. SITE READ IN THE PER-VESSEL PREDICTION OF ADENOSINE FFR≤0.80 WITH PLAQUE FEATURES ASSOCIATED WITH FALSE POSITIVES

MLA

Andrew Chiou, et al. “Cleerly™ Vs. Heartflow ™ Vs. Site Read in the Per-Vessel Prediction of Adenosine Ffr≤0.80 with Plaque Features Associated with False Positives.” Journal of the American College of Cardiology, vol. 81, Mar. 2023, p. 1384. EBSCOhost, https://doi.org/10.1016/s0735-1097(23)01828-4.

APA

Andrew Chiou, Melody Hermel, Garrett Miller, Samantha Bagsic, Alexander van Rosendael, Emem Udoh, Rajbir Sidhu, Ricardo Kosturakis, Mohammad Aziz, Christina Rodriguez Ruiz, Bahram Khadivi, Shawn Newlander, Jason Parker Brown, Martin L. Charlat, Paul S. Teirstein, Curtiss Stinis, Richard A. Schatz, Matthew J. Price, Jeffrey J. Cavendish, … George E. Wesbey. (2023). Cleerly™ Vs. Heartflow ™ Vs. Site Read in the Per-Vessel Prediction of Adenosine Ffr≤0.80 with Plaque Features Associated with False Positives. Journal of the American College of Cardiology, 81, 1384. https://doi.org/10.1016/s0735-1097(23)01828-4

Chicago

Andrew Chiou, Melody Hermel, Garrett Miller, Samantha Bagsic, Alexander van Rosendael, Emem Udoh, Rajbir Sidhu, et al. 2023. “Cleerly™ Vs. Heartflow ™ Vs. Site Read in the Per-Vessel Prediction of Adenosine Ffr≤0.80 with Plaque Features Associated with False Positives.” Journal of the American College of Cardiology 81 (March): 1384. doi:10.1016/s0735-1097(23)01828-4.